DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 39 filers reported holding DECIBEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,086,272 | +27.5% | 801,629 | 0.0% | 0.54% | +8.4% |
| Q1 2023 | $2,420,920 | +47.3% | 801,629 | 0.0% | 0.50% | +41.2% |
| Q4 2022 | $1,643,339 | -40.8% | 801,629 | 0.0% | 0.35% | -45.3% |
| Q3 2022 | $2,774,000 | -17.8% | 801,629 | 0.0% | 0.65% | -28.1% |
| Q2 2022 | $3,375,000 | +34.4% | 801,629 | -3.0% | 0.90% | +42.4% |
| Q1 2022 | $2,512,000 | -34.6% | 826,422 | 0.0% | 0.63% | -15.3% |
| Q4 2021 | $3,843,000 | -39.7% | 826,422 | 0.0% | 0.75% | -25.4% |
| Q3 2021 | $6,372,000 | -10.3% | 826,422 | 0.0% | 1.00% | +14.0% |
| Q2 2021 | $7,107,000 | -24.3% | 826,422 | 0.0% | 0.88% | -49.3% |
| Q1 2021 | $9,388,000 | – | 826,422 | – | 1.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATLAS CAPITAL ADVISORS LLC | 40,000 | $36,400 | 0.01% |